All drug discovery
October 17, 2023
Multi-omics approach unlocks discovery of natural products from bacteriaCollege of Pharmacy researchers discovered potential new compounds for synthetic biology
October 25, 2022
New enzyme inhibitor shows promise for treating cancers, autoimmune diseasesDiscovery reported in the journal Angewandte Chemie
July 28, 2022
Paul Carlier joins UIC as director of UICentre and professor of pharmaceutical sciencesPaul Carlier to join UIC Aug. 16
January 19, 2022
‘Decoy’ protein works against multiple SARS-CoV-2 variantsStudy results are reported in the journal Nature Chemical Biology
July 28, 2021
UIC awarded $6 million to develop potential COVID-19 treatmentU.S. Department of Defense grant supports pre-clinical research studies
February 8, 2021
New drug target for Ebola, Marburg virusesUIC research published in PLOS Pathogens
August 27, 2020
Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effectiveResults published in Breast Cancer Research and Treatment
August 19, 2020
Contraceptive developed at UIC approved by FDA, offers new option for womenUIC attains 4th FDA approval, leads Chicago universities in consumer drug development
June 17, 2020
Study unveils new mechanism for long-distance cell communicationNew insights could advance therapeutics targeting diseases